These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 334214)

  • 1. Pharmacokinetics of nomifensine in impaired renal function.
    Ringoir S; Lameire N; Munche M; Heptner W; Taeuber K
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):129S-134S. PubMed ID: 334214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics and bioavailability of nomifensine maleate in healthy men.
    Lassman HB; Puri SK; Ho I; Sabo R; Rosenkilde HC
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):26-32. PubMed ID: 6715299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolites.
    Puttonen J; Kantele S; Kivikko M; Häkkinen S; Harjola VP; Koskinen P; Pentikäinen PJ
    Clin Pharmacokinet; 2007; 46(3):235-46. PubMed ID: 17328582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-pass metabolism of nomifensine in dogs.
    Lindberg R; Sellman R; Iisalo E
    Eur J Drug Metab Pharmacokinet; 1985; 10(1):21-5. PubMed ID: 4029216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics and metabolism of nomifensine.
    Heptner W; Hornke I; Uihlein M
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):21-5. PubMed ID: 6370971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assessment of the effects of impaired renal function and haemodialysis on the pharmacokinetics of fluconazole.
    Toon S; Ross CE; Gokal R; Rowland M
    Br J Clin Pharmacol; 1990 Feb; 29(2):221-6. PubMed ID: 2306414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of nomifensine. Comparison of pharmacokinetics and pharmacodynamics using computer pharmaco-EEG.
    Saletu B; Grünberger J; Linzmayer L; Taeuber K
    Int Pharmacopsychiatry; 1982; 17 Suppl 1():43-72. PubMed ID: 7129805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of nomifensine by a sensitive radioimmunoassay.
    Heptner W; Badian MJ; Baudner S; Christ OE; Fraser HM; Rupp W; Weimer KE; Wissmann H
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):123S-127S. PubMed ID: 911648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of nomifensine after oral and intravenous administration.
    Lindberg RL; Syvälahti EK
    Clin Pharmacol Ther; 1986 Apr; 39(4):378-83. PubMed ID: 3956054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of meropenem in subjects with renal insufficiency.
    Leroy A; Fillastre JP; Etienne I; Borsa-Lebás F; Humbert G
    Eur J Clin Pharmacol; 1992; 42(5):535-8. PubMed ID: 1607000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.
    Erikson LO; Wåhlin-Boll E; Odar-Cederlöf I; Lindholm L; Melander A
    Eur J Clin Pharmacol; 1989; 36(2):165-74. PubMed ID: 2721541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure.
    Hoyer J; Schulte KL; Lenz T
    Clin Pharmacokinet; 1993 Mar; 24(3):230-54. PubMed ID: 8462229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of tinidazole in chronic renal failure and in patients on haemodialysis.
    Flouvat BL; Imbert C; Dubois DM; Temperville BP; Roux AF; Chevalier GC; Humbert G
    Br J Clin Pharmacol; 1983 Jun; 15(6):735-41. PubMed ID: 6871072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ciprofloxacin tablets in renal failure; influence of haemodialysis.
    Singlas E; Taburet AM; Landru I; Albin H; Ryckelinck JP
    Eur J Clin Pharmacol; 1987; 31(5):589-93. PubMed ID: 3830244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic interaction of nomifensine with a 1, 5-benzodiazepine (clobazam).
    Rupp W; Heptner W; Uihlein M; Bender R; Taeuber K
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):143S-146S. PubMed ID: 334216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ofloxacin pharmacokinetics in renal failure.
    Fillastre JP; Leroy A; Humbert G
    Antimicrob Agents Chemother; 1987 Feb; 31(2):156-60. PubMed ID: 3471179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of lamotrigine in patients with renal impairment: influence of haemodialysis.
    Fillastre JP; Taburet AM; Fialaire A; Etienne I; Bidault R; Singlas E
    Drugs Exp Clin Res; 1993; 19(1):25-32. PubMed ID: 8223137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis.
    Singlas E; Leroy A; Sultan E; Godin M; Moulin B; Taburet AM; Dhib M; Fillastre JP
    Clin Pharmacokinet; 1990 Jul; 19(1):67-79. PubMed ID: 2116256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and dosage adjustment in patients with renal dysfunction.
    Verbeeck RK; Musuamba FT
    Eur J Clin Pharmacol; 2009 Aug; 65(8):757-73. PubMed ID: 19543887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.